4processed

Form 4 — Insider Transaction

FENNEC PHARMACEUTICALS INC.(FENC)

Filing Date

May 31, 2026

Accepted

May 31, 2026

Accession No.

0001926254-26-000008

CIK

0001211583

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Hackman Jeffrey S.Chief Executive OfficerOther1.2K$062.8KCommon SharesMay 31, 2026